Science Explorer Back to mapMap
Discussion
Company · Gaithersburg · United States

Novavax (United States)

novavax.comROR OpenAlex
Research works
110
▲ 137% vs 2018-21
Citations
4.3k
39.1 per fractional work
Top-10% rate
15.8%
all institutions 10.0%
Open access
82%
world 40%
International
19%
world 18%
Novavax (United States)

Not ranked overall: Novavax (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Novavax (United States) work in?

In 2022-now, 59% of research at Novavax (United States) is in Health Sciences, 27% in Life Sciences. Its largest fields are Medicine (58%), Biochemistry, Genetics and Molecular Biology (12%), Immunology and Microbiology (10%). It does 2.3× the world's share of Health Sciences.

Health Sciences: 32 fractional works · 59.5% of its workMedicine: 31 fractional works · 58.4% of its workInfectious Diseases: 18 fractional works · 33.0% of its workEpidemiology: 6 fractional works · 10.5% of its workNeurology: 1 fractional works · 2.0% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.8% of its workSurgery: 1 fractional works · 1.6% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.5% of its workPharmacology: 1 fractional works · 1.2% of its workObstetrics and Gynecology: 1 fractional works · 1.1% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 1.1% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.0% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.9% of its workDermatology: 0 fractional works · 0.8% of its workReproductive Medicine: 0 fractional works · 0.6% of its workEmergency Medicine: 0 fractional works · 0.3% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.3% of its workImmunology and Allergy: 0 fractional works · 0.3% of its workHealth Informatics: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 0.7% of its workGeneral Health Professions: 0 fractional works · 0.7% of its workVeterinary: 0 fractional works · 0.3% of its workSmall Animals: 0 fractional works · 0.3% of its workLife Sciences: 14 fractional works · 26.5% of its workBiochemistry, Genetics and Molecular Biology: 6 fractional works · 12.0% of its workMolecular Biology: 6 fractional works · 11.4% of its workGenetics: 0 fractional works · 0.3% of its workBiophysics: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workImmunology and Microbiology: 5 fractional works · 10.1% of its workImmunology: 5 fractional works · 8.7% of its workMicrobiology: 1 fractional works · 1.1% of its workVirology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 2 fractional works · 4.3% of its workAnimal Science and Zoology: 2 fractional works · 3.9% of its workFood Science: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.1% of its workNeuroscience: 0 fractional works · 0.1% of its workSocial Sciences: 5 fractional works · 8.8% of its workSocial Sciences: 4 fractional works · 7.6% of its workHealth: 4 fractional works · 7.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPsychology: 0 fractional works · 0.7% of its workApplied Psychology: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.3% of its workEconomics and Econometrics: 0 fractional works · 0.3% of its workDecision Sciences: 0 fractional works · 0.2% of its workPhysical Sciences: 3 fractional works · 5.2% of its workMathematics: 1 fractional works · 2.0% of its workModeling and Simulation: 1 fractional works · 1.9% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemistry: 1 fractional works · 1.6% of its workSpectroscopy: 0 fractional works · 0.9% of its workAnalytical Chemistry: 0 fractional works · 0.6% of its workComputer Science: 1 fractional works · 1.0% of its workComputational Theory and Mathematics: 0 fractional works · 0.7% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.3% of its workEngineering: 0 fractional works · 0.6% of its workMedia Technology: 0 fractional works · 0.3% of its workBiomedical Engineering: 0 fractional works · 0.2% of its workMaterials Science: 0 fractional works · 0.0% of its workALL ITS WORKNovavax (UnitedStates)53fractional works, 2022-now
Life Sciences27%Physical Sciences5%Health Sciences59%Social Sciences9%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 17 fields, with their numbers
    1. Medicine3158.4%
    2. Health Professions00.7%
    3. Veterinary00.3%
    1. Biochemistry, Genetics and Molecular Biology612.0%
    2. Immunology and Microbiology510.1%
    3. Agricultural and Biological Sciences24.3%
    4. Pharmacology, Toxicology and Pharmaceutics00.1%
    5. Neuroscience00.1%
    1. Social Sciences47.6%
    2. Psychology00.7%
    3. Economics, Econometrics and Finance00.3%
    4. Decision Sciences00.2%
    1. Mathematics12.0%
    2. Chemistry11.6%
    3. Computer Science11.0%
    4. Engineering00.6%
    5. Materials Science00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.90× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.25× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 9.99× its world share, 5 worksImmunology and Micro…Neuroscience: 0.06× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.30× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.00× its world share, 1 worksChemistryComputer Science: 0.13× its world share, 0 worksComputer ScienceEngineering: 0.04× its world share, 0 worksEngineeringMaterials Science: 0.01× its world share, 0 worksMaterials ScienceMathematics: 1.72× its world share, 1 worksMathematicsHealth Professions: 0.28× its world share, 0 worksHealth ProfessionsMedicine: 3.04× its world share, 31 worksMedicineVeterinary: 2.30× its world share, 0 worksVeterinaryDecision Sciences: 0.16× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.15× its world share, 0 worksEconomics, Econometr…Psychology: 0.23× its world share, 0 worksPsychologySocial Sciences: 0.60× its world share, 4 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 10.0×. Every wedge is a field page.

All 17 fields, with their numbers
  1. Immunology and Microbiology9.99×5 works
  2. Medicine3.04×31 works
  3. Veterinary2.30×0 works
  4. Biochemistry, Genetics and Molecular Biology2.25×6 works
  5. Mathematics1.72×1 works
  6. Chemistry1.00×1 works
  7. Agricultural and Biological Sciences0.90×2 works
  8. Social Sciences0.60×4 works
  9. Pharmacology, Toxicology and Pharmaceutics0.30×0 works
  10. Health Professions0.28×0 works
  11. Psychology0.23×0 works
  12. Decision Sciences0.16×0 works
  13. Economics, Econometrics and Finance0.15×0 works
  14. Computer Science0.13×0 works
  15. Neuroscience0.06×0 works
  16. Engineering0.04×0 works
  17. Materials Science0.01×0 works

Who are the top researchers at Novavax (United States)?

Ranked on the quality score, Gale Smith, Gregory M. Glenn and Nita Patel lead among researchers whose main affiliation is Novavax (United States).

  1. 1 Gale Smith United States · #26,018 worldwide 17k citations · 174 works
  2. 2 Gregory M. Glenn United States · #82,727 worldwide 19k citations · 281 works
  3. 3 Nita Patel United States · #107,877 worldwide 8.1k citations · 105 works
  4. 4 Filip Dubovsky United States · #128,225 worldwide 7.2k citations · 89 works
  5. 5 Louis F Fries United States · #137,786 worldwide 8.6k citations · 130 works
  6. 6 Vivek Shinde United States · #149,897 worldwide 6.5k citations · 74 works
  7. 7 Mingzhu Zhu United States · #166,829 worldwide 4.4k citations · 85 works
  8. 8 Joyce S. Plested United States · #203,389 worldwide 4.3k citations · 103 works
  9. 9 Shane Cloney-Clark United States · #247,481 worldwide 2.6k citations · 57 works
  10. 10 Gary R. Albert United States · #261,928 worldwide 3.1k citations · 29 works
All ranked researchers at Novavax (United States)

What are the most cited papers from Novavax (United States)?

The most cited paper from Novavax (United States) is "Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant" (Vivek Shinde et al., 2021), with 667 citations. Next come "SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice" (529) and "Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial" (473).

Most cited papers
#PaperReleasedCitations
1 Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant Vivek Shinde et al. · New England Journal of Medicine Open access 5 May 2021 667
2 SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice Jing-Hui Tian et al. · Nature Communications Open access 14 Jan 2021 529
3 Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial Mehreen S. Datoo et al. · The Lancet Open access May 2021 473
4 Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico Lisa M. Dunkle et al. · New England Journal of Medicine Open access 15 Dec 2021 461
5 Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants Shabir Ahmed Madhi et al. · New England Journal of Medicine Open access 29 Jul 2020 439
All 59 most cited papers, with filters and sorting

Which keywords describe research at Novavax (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Pandemic, SARS-CoV-2, Vaccine, ACE2 Receptor, Coronavirus, Immunity, Epidemiology and Viral Transmission.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Pandemic18▲ 34×5 topics
  2. SARS-CoV-218▲ 111×6 topics
  3. Vaccine16▲ 75×8 topics
  4. ACE2 Receptor16▲ 130×2 topics
  5. Epidemiology15▲ 6.9×21 topics
  6. Coronavirus14▲ 135×3 topics
  7. Immunity14▲ 65×4 topics
  8. Viral Transmission12▲ 166×2 topics
  9. antibody12▲ 231×1 topic
  10. spike protein12▲ 231×1 topic
  11. Immune Response8▲ 25×9 topics
  12. Pathogenesis6▲ 24×11 topics
  13. Antigen Presentation6▲ 122×2 topics
  14. Epitope Prediction4▲ 290×1 topic
  15. Peptide-MHC Binding4▲ 290×1 topic
  16. Health Behavior4▲ 84×2 topics
  17. Thrombosis4▲ 29×3 topics
  18. COVID-19 Vaccine4▲ 107×1 topic
  19. Vaccine Hesitancy4▲ 118×1 topic
  20. COVID-194▲ 5.4×9 topics
  21. Clinical Characteristics4▲ 56×1 topic
  22. Cytokine Storm4▲ 67×1 topic
  23. Infectious Diseases3▲ 15×2 topics
  24. Genomics2▲ 15×2 topics
  25. Influenza2▲ 108×1 topic
  26. Virus2▲ 47×1 topic
  27. Vaccine Development2▲ 17×3 topics
  28. Human Metapneumovirus2▲ 89×1 topic
  29. Respiratory Syncytial Virus2▲ 89×1 topic
  30. Circovirus2▲ 129×1 topic
  31. Porcine Reproductive and Respiratory Syndrome Virus2▲ 129×1 topic
  32. Epigenetic Reprogramming2▲ 34×2 topics
  33. Innate Immunity2▲ 9.7×3 topics
  34. Innate Memory2▲ 123×1 topic
  35. Trained Immunity2▲ 123×1 topic
  36. Dendritic Cells1▲ 29×2 topics
  37. Cancer Immunotherapy1▲ 16×1 topic
  38. Monoclonal Antibodies1▲ 27×3 topics
  39. Tumor Antigen1▲ 41×1 topic
  40. Therapeutic Antibodies1▲ 33×2 topics

Which research topics does Novavax (United States) publish most on?

By volume in 2022-now: SARS-CoV-2 and COVID-19 Research, vaccines and immunoinformatics approaches, Vaccine Coverage and Hesitancy and COVID-19 Clinical Research Studies.

SARS-CoV-2 and COVID-19 …12SARS-CoV-2 and COVID-19 Research: 12 fractional worksvaccines and immunoinfor…5vaccines and immunoinformatics approaches: 5 fractional worksVaccine Coverage and Hes…4Vaccine Coverage and Hesitancy: 4 fractional worksCOVID-19 Clinical Research Studies: 4 fractional worksInfluenza Virus Research Studies: 2 fractional worksRespiratory viral infect…2Respiratory viral infections research: 2 fractional worksAnimal Virus Infections Studies: 2 fractional worksImmune responses and vaccinations: 2 fractional worksImmunotherapy and Immune Responses: 1 fractional worksSARS-CoV-2 detection and testing: 1 fractional works
Infectious DiseasesMolecular BiologyHealthEpidemiology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 12 works
  2. 2 vaccines and immunoinformatics approaches Molecular Biology 5 works
  3. 3 Vaccine Coverage and Hesitancy Health 4 works
  4. 4 COVID-19 Clinical Research Studies Infectious Diseases 4 works
  5. 5 Influenza Virus Research Studies Epidemiology 2 works
  6. 6 Respiratory viral infections research Epidemiology 2 works
  7. 7 Animal Virus Infections Studies Animal Science and Zoology 2 works
  8. 8 Immune responses and vaccinations Immunology 2 works
  9. 9 Immunotherapy and Immune Responses Immunology 1 works
  10. 10 SARS-CoV-2 detection and testing Infectious Diseases 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available81.9%not open18.1%

World: 40% of research is openly available.

with international co-authors18.6%domestic only81.4%

World: 18% is written across borders.

How has Novavax (United States)'s research output changed?

Output in 2022-2025 was 137% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Novavax (United States) as a percentage of every work published that year, 0.00017% in 2024.

still counting0.00010%0.00020%0.00030%Novavax (United States)0.00026% in 2025200020102020

Fractional works of Novavax (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Gaithersburg

All research institutions in Gaithersburg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Novavax (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.